Cargando…
Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
Autores principales: | Honore, Patrick M., Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055096/ https://www.ncbi.nlm.nih.gov/pubmed/32127029 http://dx.doi.org/10.1186/s13054-020-2813-y |
Ejemplares similares
-
Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019) -
No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020) -
Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019) -
Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
por: Honore, Patrick M., et al.
Publicado: (2020) -
Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2020)